Share of consumption of biosimilar drugs in Italy 2016-2018

Between 2016 and 2018, the share of biosimilars consumed out of the total marketed molecules for which the biosimilar variation was available, increased from 13 to 17 percent. However, the level of consumption peaked in 2017 when biosimilars accounted for 19 percent of total drug consumption. Biosimilars are drugs of biological origin which are very similar in function and effect to previously approved biological products.

Share of consumption of biosimilar drugs* in Italy from 2016 to 2018

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

March 2019



Survey time period

2016 to 2018

Supplementary notes

*Share out of total marketed molecules for which is available the biosimilar variation.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Generics and biosimilars in Italy"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.